Hermes Consilium, an exclusive distributor of best-quality ingredients for nutritional products, is announcing its acquisition by ANJAC Health & Beauty, a French industrial group that now comprises 17 complementary companies with R&D and production capabilities in the fields of health, beauty, personal care, and food supplements. The acquisition marks a new era of opportunity for Hermes Consilium and its sister companies, PharmaLinea and ErgoPharma, reinforcing their growth trajectory and enabling access to new technologies, innovation possibilities, and partners.
ANJAC Health & Beauty, the partner of pharmaceutical laboratories and beauty and wellness brands
ANJAC Health & Beauty is a French family-owned industrial Group specializing in the formulation, manufacturing, and filling of cosmetics, medical devices, drugs, and food supplements. Integrating what is now 17 companies with 17 R&D sites and 24 manufacturing sites across Europe and North America, ANJAC creates, develops, and manufactures raw materials to finished products. With the acquisition of Health Chain Group (HCG), composed of sister companies PharmaLinea, Hermes Consilium, and ErgoPharma, ANJAC follows its broader strategy to strengthen its health and pharma activities, particularly by expanding its nutrition and innovative food ingredients offering. The goal is to bridge food and supplementation to provide unique health solutions, backed by clinical studies. The acquisition also enhances ANJAC’s commercial presence in high-potential markets across Central and Eastern Europe, as well as in Asia, the Middle East, and North America. Founded in 2008, ANJAC Health & Beauty Group now has a consolidated workforce of over 3.300 and a 2025 turnover expected of nearly €800million, positioning it as a leading comprehensive R&D and production partner for pharmaceutical laboratories, beauty, and wellness brands.
Synergies and shared vision of the future
The partnership between ANJAC and HCG opens new pathways for advancing product innovation, scientific research, and comprehensive service for client brands. Hermes Consilium will retain its distinctive identity and dedication to the principles that have defined its success. It will continue to operate as a trusted partner to nutritional product manufacturers, while benefiting from ANJAC’s extensive infrastructure, cross-sector expertise, and R&D resources.
Blaž Gorjup, Founder of HCG: “Hermes Consilium and Health Chain Group were founded with a simple yet ambitious goal: to bring more science, integrity, and trust to the nutraceutical industry. Seeing that vision grow into a group recognized across the world fills me with pride and gratitude. Joining forces with ANJAC will allow HCG to reach even higher while staying true to its values. It’s because of this strong foundation and bright outlook that I chose to remain a minority shareholder and continue to be available to the company as it moves forward. My sincere thanks go to everyone who has contributed to this journey.”
Anton Oražem, CEO of HCG: “This marks an incredibly exciting new chapter for HCG. Becoming part of ANJAC Health & Beauty represents both a great milestone and a strong confirmation of how far we’ve come — the culmination of many years of hard work in establishing our company, our processes, our network, and our product pipeline. We are truly proud to join such a renowned group that shares the same values, entrepreneurial DNA, and long-term vision for the future. With ANJAC’s extensive network across the health and beauty industries, HCG will gain access to new technologies, new innovation possibilities, and new partners — all of which will further strengthen our ability to deliver premium, clinically substantiated solutions to our clients. This partnership opens an era of extraordinary opportunity. It will give wings to our story, while at the same time complementing and completing the offering that ANJAC provides to its partners worldwide. We are excited about the journey ahead and the value this collaboration will bring to both organizations.”
The acquisition of Hermes Consilium and HCG marks a new growth driver for ANJAC in the food supplement market, expanding its portfolio of proprietary ingredients, technologies, and clinical substantiation. The commercial synergies between ANJAC and HCG will enhance international growth in the health and pharma segments—a strategic step toward ANJAC’s ambition to strengthen its global position in the nutraceutical market.
Aurélien Chaufour, President of the ANJAC Group: “We are delighted to welcome HCG to the ANJAC Group. This partnership reflects our strong ambitions in the health and pharma segment, our strategy in clinically backed food and nutraceuticals solutions, and the continued acceleration of our international growth. We share with HCG a common vision: delivering innovative, high-performance solutions with a premium level of service recognized by our clients.”